Home > Publications database > Mechanisms controlling cellular and systemic iron homeostasis. > print |
001 | 284407 | ||
005 | 20240229155051.0 | ||
024 | 7 | _ | |a 10.1038/s41580-023-00648-1 |2 doi |
024 | 7 | _ | |a pmid:37783783 |2 pmid |
024 | 7 | _ | |a 1471-0072 |2 ISSN |
024 | 7 | _ | |a 1471-0080 |2 ISSN |
024 | 7 | _ | |a altmetric:154863049 |2 altmetric |
037 | _ | _ | |a DKFZ-2023-01996 |
041 | _ | _ | |a English |
082 | _ | _ | |a 570 |
100 | 1 | _ | |a Galy, Bruno |0 P:(DE-He78)00eb6e35f6edc7e5fcb2aacc7a21f891 |b 0 |e First author |u dkfz |
245 | _ | _ | |a Mechanisms controlling cellular and systemic iron homeostasis. |
260 | _ | _ | |a London |c 2024 |b Macmillan |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1706708200_24337 |2 PUB:(DE-HGF) |x Review Article |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
500 | _ | _ | |a #EA:F170# / 2024 Feb;25(2):133-155 |
520 | _ | _ | |a In mammals, hundreds of proteins use iron in a multitude of cellular functions, including vital processes such as mitochondrial respiration, gene regulation and DNA synthesis or repair. Highly orchestrated regulatory systems control cellular and systemic iron fluxes ensuring sufficient iron delivery to target proteins is maintained, while limiting its potentially deleterious effects in iron-mediated oxidative cell damage and ferroptosis. In this Review, we discuss how cells acquire, traffick and export iron and how stored iron is mobilized for iron-sulfur cluster and haem biogenesis. Furthermore, we describe how these cellular processes are fine-tuned by the combination of various sensory and regulatory systems, such as the iron-regulatory protein (IRP)-iron-responsive element (IRE) network, the nuclear receptor co-activator 4 (NCOA4)-mediated ferritinophagy pathway, the prolyl hydroxylase domain (PHD)-hypoxia-inducible factor (HIF) axis or the nuclear factor erythroid 2-related factor 2 (NRF2) regulatory hub. We further describe how these pathways interact with systemic iron homeostasis control through the hepcidin-ferroportin axis to ensure appropriate iron fluxes. This knowledge is key for the identification of novel therapeutic opportunities to prevent diseases of cellular and/or systemic iron mismanagement. |
536 | _ | _ | |a 316 - Infektionen, Entzündung und Krebs (POF4-316) |0 G:(DE-HGF)POF4-316 |c POF4-316 |f POF IV |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de |
700 | 1 | _ | |a Conrad, Marcus |0 0000-0003-1140-5612 |b 1 |
700 | 1 | _ | |a Muckenthaler, Martina |b 2 |
773 | _ | _ | |a 10.1038/s41580-023-00648-1 |0 PERI:(DE-600)2028906-6 |n 2 |p 133-155 |t Nature reviews |v 25 |y 2024 |x 1471-0072 |
909 | C | O | |p VDB |o oai:inrepo02.dkfz.de:284407 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 0 |6 P:(DE-He78)00eb6e35f6edc7e5fcb2aacc7a21f891 |
913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-316 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Infektionen, Entzündung und Krebs |x 0 |
914 | 1 | _ | |y 2023 |
915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |d 2023-08-24 |w ger |
915 | _ | _ | |a DEAL Nature |0 StatID:(DE-HGF)3003 |2 StatID |d 2023-08-24 |w ger |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2023-08-24 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2023-08-24 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2023-08-24 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2023-08-24 |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2023-08-24 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2023-08-24 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2023-08-24 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1120 |2 StatID |b BIOSIS Reviews Reports And Meetings |d 2023-08-24 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2023-08-24 |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b NAT REV MOL CELL BIO : 2022 |d 2023-08-24 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2023-08-24 |
915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2023-08-24 |
915 | _ | _ | |a IF >= 90 |0 StatID:(DE-HGF)9990 |2 StatID |b NAT REV MOL CELL BIO : 2022 |d 2023-08-24 |
920 | 1 | _ | |0 I:(DE-He78)F170-20160331 |k F170 |l F170 Virus-assoziierte Karzinogenese |x 0 |
920 | 0 | _ | |0 I:(DE-He78)F170-20160331 |k F170 |l F170 Virus-assoziierte Karzinogenese |x 0 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a I:(DE-He78)F170-20160331 |
980 | _ | _ | |a UNRESTRICTED |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|